Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q3 FY26 results · Oct–Dec 2025
Divi's Laboratories reported revenue from operations of ₹2,604.00 crore (up 12.3% from Q3 FY25) and net profit of ₹583.00 crore (down 1.0% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,604.00 | 2,319.00 | +12.3% | 2,715.00 | −4.1% |
| Other income | 88.00 | 82.00 | +7.3% | 145.00 | −39.3% |
| Total income | 2,692.00 | 2,401.00 | +12.1% | 2,860.00 | −5.9% |
| Profit before tax | 780.00 | 726.00 | +7.4% | 912.00 | −14.5% |
| Net profit for the period | 583.00 | 589.00 | −1.0% | 689.00 | −15.4% |
| EPS, basic (₹) | 21.98 | 22.20 | −1.0% | 25.97 | −15.4% |
| Net margin (%) | 22.4 | 25.4 | 25.4 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,578.00 | 2,297.00 | +12.2% | 2,660.00 | −3.1% |
| Other income | 87.00 | 82.00 | +6.1% | 146.00 | −40.4% |
| Total income | 2,665.00 | 2,379.00 | +12.0% | 2,806.00 | −5.0% |
| Profit before tax | 798.00 | 730.00 | +9.3% | 920.00 | −13.3% |
| Net profit for the period | 598.00 | 594.00 | +0.7% | 696.00 | −14.1% |
| EPS, basic (₹) | 22.56 | 22.39 | +0.8% | 26.24 | −14.0% |
| Net margin (%) | 23.2 | 25.9 | 26.2 |
Consolidated
- Filed with BSE
- 11 Feb 2026, 14:15 IST
- Board meeting
- 11 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Feb 2026, 14:15 IST
- Board meeting
- 11 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE